Nu Skin Enterprises Inc. (NUS) Financial Statements (2025 and earlier)

Company Profile

Business Address 75 WEST CENTER ST
PROVO, UT 84601
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 5122 - Drugs, Drug Proprietaries, and Druggists' Sundries (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments232,921221,206267,816249,987252,326246,715
Cash and cash equivalents224,250212,532256,057233,314235,554229,941
Short-term investments8,6718,67411,75916,67316,77216,774
Receivables71,55467,04172,87977,25167,16660,008
Inventory, net of allowances, customer advances and progress billings243,994265,100279,978291,103372,250366,537
Inventory243,994265,100279,978291,103372,250366,537
Prepaid expense   14,932   
Deferred costs   10,227   
Derivative instruments and hedges, assets   8,955   
Deposits current assets   2,295   
Other current assets   17,918   
Other undisclosed current assets105,93793,91326,87182,781100,833100,302
Total current assets:654,406647,260701,871701,122792,575773,562
Noncurrent Assets
Operating lease, right-of-use asset88,07193,09290,10786,31594,70798,683
Property, plant and equipment411,918422,818432,965428,932430,328437,986
Intangible assets, net (including goodwill)188,349332,701336,077338,441342,088271,143
Goodwill99,885230,768230,768229,469229,469206,432
Intangible assets, net (excluding goodwill)88,464101,933105,309108,972112,61964,711
Other noncurrent assets243,228246,044245,443238,281234,078243,271
Total noncurrent assets:931,5661,094,6551,104,5921,091,9691,101,2011,051,083
TOTAL ASSETS:1,585,9721,741,9151,806,4631,793,0911,893,7761,824,645
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities278,593279,305303,871294,015305,039325,268
Accounts payable36,30532,23743,50548,58349,52949,494
Accrued liabilities242,288247,068260,366245,432255,510275,774
Deferred revenue 11,800     
Debt30,00030,00025,000140,000140,00047,500
Other undisclosed current liabilities (11,800)     
Total current liabilities:308,593309,305328,871434,015445,039372,768
Noncurrent Liabilities
Long-term debt and lease obligation428,327453,183478,040362,896367,753372,609
Long-term debt, excluding current maturities428,327453,183478,040362,896367,753372,609
Liabilities, other than long-term debt162,888169,221177,584173,993185,639186,298
Other liabilities92,57095,023106,641105,785111,152107,522
Operating lease, liability70,31874,19870,94368,20874,48778,776
Total noncurrent liabilities:591,215622,404655,624536,889553,392558,907
Total liabilities:899,808931,709984,495970,904998,431931,675
Equity
Equity, attributable to parent686,164810,206821,968822,187895,345892,970
Common stock919191919191
Treasury stock, value(1,564,090)(1,564,942)(1,570,440)(1,570,718)(1,557,777)(1,559,080)
Additional paid in capital621,440618,706621,853619,193615,579611,483
Accumulated other comprehensive loss(116,995)(110,607)(100,006)(108,836)(101,446)(91,005)
Retained earnings1,745,7181,866,9581,870,4701,882,4571,938,8981,931,481
Total equity:686,164810,206821,968822,187895,345892,970
TOTAL LIABILITIES AND EQUITY:1,585,9721,741,9151,806,4631,793,0911,893,7761,824,645

Income Statement (P&L) ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Revenues439,081417,306488,640498,772500,257481,462
Cost of revenue
(Cost of Goods and Services Sold)
(131,904)(123,242)(136,215)(206,505)(135,542)(133,588)
Gross profit:307,177294,064352,425292,267364,715347,874
Operating expenses(432,734)(285,242)(336,362)(318,632)(322,209)(331,810)
Operating income (loss):(125,557)8,82216,063(26,365)42,50616,064
Nonoperating income (expense)629(396)(6,735)(8,086)(5,393)(1,476)
Gain (loss), foreign currency transaction, before tax  (1,639)(870)  2,102
Interest and debt expense(94)(7,325)(25,220)(123)(123)(134)
Income (loss) from continuing operations before equity method investments, income taxes:(125,022)1,101(15,892)(34,574)36,99014,454
Other undisclosed income (loss) from continuing operations before income taxes(6,626) 25,220123123134
Income (loss) from continuing operations before income taxes:(131,648)1,1019,328(34,451)37,11314,588
Income tax expense (benefit)13,390(1,634)(2,046)(2,504)(10,221)(3,212)
Net income (loss) available to common stockholders, diluted:(118,258)(533)7,282(36,955)26,89211,376

Comprehensive Income ($ in thousands)

9/30/2024
Q3
6/30/2024
Q2
3/31/2024
Q1
12/31/2023
Q4
9/30/2023
Q3
6/30/2023
Q2
3/31/2023
Q1
Net income (loss):(118,258)(533)7,282(36,955)26,89211,376
Other comprehensive income   558  68
Comprehensive income (loss):(118,258)(533)7,840(36,955)26,89211,444
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(6,388)(10,601)8,272(7,390)(10,441)(4,564)
Comprehensive income (loss), net of tax, attributable to parent:(124,646)(11,134)16,112(44,345)16,4516,880

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: